Petiq, Inc.

  • Earnings Score
  • Moat Score
  • Safety Score
  • Market Cap $909.22M
  • PE 69
  • Debt $449.09M
  • Cash $84.13M
  • EV $1.27B
  • FCF $11.98M

Earnings

loading chart...

Sales & Net Margins

loading chart...
Earnings$13.19M
EBIT$49.34M
ROE5%
ROA6%
FCF$11.98M
Equity$260.32M
Growth Stability1
PE68.92
PEG261.26
PB3.49
P/FCF75.89
P/S0.8
Price/Cash0.09
Debt/Equity1.73
Debt/FCF37.49
Net Margins5%
Gross Margins25%
Op. Margins4%
Earnings CAGR0%
Sales Growth YoY5%
Sales Growth QoQ7%
Sales CAGR16%
FCF CAGR3%
Equity CAGR12%
Earnings Stability-0.04
Earnings Growth YoY62%
Earnings Growth QoQ3%
Earnings CAGR 5Y0%
Sales CAGR 5Y11%
FCF CAGR 5Y11%
Equity CAGR 5Y-8%
Earnings CAGR 3Y9%
Sales CAGR 3Y9%
FCF CAGR 3Y13%
Equity CAGR 3Y-3%
Market Cap$909.22M
Revenue$1.13B
Assets$894.39M
Total Debt$449.09M
Cash$84.13M
Shares Outstanding29.35M
EV1.27B
Earnings Score6%
Moat Score69%
Safety Score68%
Final Score48%
Working Capital288.37M
Current Ratio2.58
Gross Profit$279.43M
Shares Growth 3y1%
Equity Growth QoQ9%
Equity Growth YoY10%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...
PetIQ Inc is a manufacturer and distributor of health and wellness products for dogs and cats. The company offers veterinarian-grade pet Rx medications, OTC flea and tick preventatives, vitamins treats, nutritional supplements, and hygiene products. The group operates in two segments namely the Products and Services segments. It also provides third-party products to retailers which for a long time were primarily available from veterinary clinics only. Its proprietary brands include PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, TruProfen, Betsy Farms, PetAction, Minties, Vera and Delightibles. The company generates maximum revenue from Products segment.

SEC Filings

Direct access to Petiq, Inc. (PETQ) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

  • 2024
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2023
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2022
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31

Sector Comparison

How does Petiq, Inc. compare to its competitors?

Not enough data to generate a comparison chart between Petiq, Inc. and its competitors. Please check back later.

Peter Lynch's Chart

This chart shows the current pricing of Petiq, Inc. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR 0%
Stability -4%
loading chart...

Petiq, Inc. Discounted Cash Flow

Fully customizable DCF calculator online for Petiq, Inc..

= $152M
012345678910TV
fcf$12M$12M$13M$13M$14M$14M$15M$15M$16M$16M$17M$168M
DCF$11M$11M$10M$9.4M$8.8M$8.3M$7.8M$7.3M$6.9M$6.5M$65M
Value$152M

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years12/201512/201612/201812/201912/202012/202112/202212/2023TTM
Net Margins-1%-2%-0%-2%-10%-2%-5%0%5%
ROA-1%--0%-0%2%-2%4%6%
ROE--8%-0%-4%-28%-6%-23%1%5%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years12/201512/201612/201812/201912/202012/202112/202212/2023TTM
Debt over FCF--10.01-24.39-13.65-61.6112.698.5837.49
Debt over Equity-0.690.340.781.251.812.162.031.73
Growth Stability--------1

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years12/201512/201612/201812/201912/202012/202112/202212/2023CAGR 5Y
Revenue YoY growth--3%164%34%10%20%-1%20%11%
Earnings YoY growth-152%-77%2K%467%-80%197%-104%0%
Equity YoY growth--7%647%2%-10%-13%-17%5%-8%
FCF YoY growth--63%560%-154%-356%-72%-580%46%11%